100 related articles for article (PubMed ID: 3046744)
1. Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function.
Conkling PR; Chua CC; Nadler P; Greenberg CS; Doty E; Misukonis MA; Haney AF; Bast RC; Weinberg JB
Cancer Res; 1988 Oct; 48(19):5604-9. PubMed ID: 3046744
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
3. Study of interaction between the polyoxidonium immunomodulator and the human immune system cells.
Dyakonova VA; Dambaeva SV; Pinegin BV; Khaitov RM
Int Immunopharmacol; 2004 Dec; 4(13):1615-23. PubMed ID: 15454114
[TBL] [Abstract][Full Text] [Related]
4. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
6. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
Grey ST; Hancock WW
J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
[TBL] [Abstract][Full Text] [Related]
7. Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan.
Mulder AB; Zwaveling JH; Smid WM; Maring JK; van Ginkel RJ; Girbes AR; Schraffordt Koops H; van der Meer J
Thromb Haemost; 1996 Dec; 76(6):897-901. PubMed ID: 8972008
[TBL] [Abstract][Full Text] [Related]
8. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
Hallahan DE; Vokes EE; Rubin SJ; O'Brien S; Samuels B; Vijaykumar S; Kufe DW; Phillips R; Weichselbaum RR
Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
[TBL] [Abstract][Full Text] [Related]
9. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells.
Zhang Z; Bagby GJ; Stoltz D; Oliver P; Schwarzenberger PO; Kolls JK
Alcohol Clin Exp Res; 2001 Mar; 25(3):444-9. PubMed ID: 11290857
[TBL] [Abstract][Full Text] [Related]
10. Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes.
Liese AM; Siddiqi MQ; Siegel JH; Denny T; Spolarics Z
J Leukoc Biol; 2001 Aug; 70(2):289-96. PubMed ID: 11493622
[TBL] [Abstract][Full Text] [Related]
11. Expression of the angiogenic factor thymidine phosphorylase in THP-1 monocytes: induction by autocrine tumor necrosis factor-alpha and inhibition by aspirin.
Zhu GH; Schwartz EL
Mol Pharmacol; 2003 Nov; 64(5):1251-8. PubMed ID: 14573775
[TBL] [Abstract][Full Text] [Related]
12. Endotoxic activities of tumor necrosis factor independent of IL1 secretion by macrophages/monocytes.
Männel DN; Falk W; Northoff H
Lymphokine Res; 1987; 6(3):151-9. PubMed ID: 3114568
[TBL] [Abstract][Full Text] [Related]
13. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes.
Osterud B; Rao LV; Olsen JO
Thromb Haemost; 2000 Jun; 83(6):861-7. PubMed ID: 10896239
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-alpha production in vitro.
Darville T; Tabor D; Simpson K; Jacobs RF
Pediatr Res; 1994 Apr; 35(4 Pt 1):397-403. PubMed ID: 8047375
[TBL] [Abstract][Full Text] [Related]
15. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release.
Kitagawa S; Yuo A; Yagisawa M; Azuma E; Yoshida M; Furukawa Y; Takahashi M; Masuyama J; Takaku F
Exp Hematol; 1996 Mar; 24(4):559-67. PubMed ID: 8608807
[TBL] [Abstract][Full Text] [Related]
16. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
19. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells.
Eliassen LT; Rekdal O; Svendsen JS; Osterud B
Thromb Haemost; 2000 Apr; 83(4):598-604. PubMed ID: 10780324
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Schwarz EM; Lu AP; Goater JJ; Benz EB; Kollias G; Rosier RN; Puzas JE; O'Keefe RJ
J Orthop Res; 2000 May; 18(3):472-80. PubMed ID: 10937636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
